Qi Wang

5PUBLICATIONS
14CO-AUTHORS
Regenerative medicine (incl. stem cells)Gastroenterology and hepatologyPublic health nutritionMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 22, 2026
GSTM3 Knockdown Promotes Liver Fibrosis Reversal by Inhibiting Hepatic Stellate Cell Activation via PPARĪ³ Signaling.

|May 26, 2025
Patients with chronic hepatitis B exhibiting significant inflammation and fibrosis should pay particular attention to the status of hepatic steatosis during antiviral therapy.

Bingqing Yang, Tianyuan Yang, Chenxue Hou

|Apr 29, 2025
Targeting Insulin Resistance and Liver Fibrosis: CKD Screening Priorities in MASLD.

Tianyuan Yang, Bingqing Yang, Jingya Yin

|Jan 18, 2023
Mitochondrial pyruvate carrier 1 regulates fatty acid synthase lactylation and mediates treatment of nonalcoholic fatty liver disease.

Ruxin Gao, Yue Li, Zhimeng Xu

|May 05, 2021
Serum markers for predicting advanced fibrosis in patients with chronic hepatitis B and nonalcoholic fatty liver disease.

Qi Wang, Wen Xie, Ligai Liu

Pageof 1

Frequent Collaborators

2 joint publications

Yue Li

1 joint publications

Wen Xie

1 joint publications

Ligai Liu

1 joint publications

Peng Wang